Angewandte
Chemie
Scheme 5. Synthesis of macrolides 2c–h. Reagents and conditions:
a) second-generation Grubbs catalyst[14] (0.1 equiv), toluene, 1108C,
20 min; b) H2, Pd/C (0.1 equiv), EtOAc, 8 h.
Scheme 7. Total synthesis of (2R,4R,7R,9R,16S)-spongidepsin (1).
Reagents and conditions: a) Ph3P (2 equiv), imidazole (3 equiv), I2
(1.5 equiv), THF, 20 min, 82%; b) allyl tri-n-butyltin (3 equiv), AIBN
(0.5 equiv), benzene, 808C, 4 h, 85%; c) K2OsO4 (0.2 equiv), NaIO4
(6 equiv), THF-H2O (2:1), 1.5 h, 87%; d) K2CO3 (1.5 equiv), Bestmann
reagent (1.5 equiv), MeOH, 3 h, 75%. AIBN=2,2’-azobisisobutyroni-
trile, Bestmann reagent=dimethyl-1-diazo-2-oxopropylphosphonate.
(2R,4R,7R,9R,16S)-1: [a]D = À 67.3 (c = 1.00, MeOH); Spon-
gia isolate 1:[1] [a]D = À 61.8 (c = 1.4, MeOH)].
In summary, this work highlights the convergence of
synthetic design, methodology, and spectroscopic analyses to
fully define the structure and provide an alternative source of
the recently described antiproliferative natural product
spongidepsin. The complete stereochemical assignment and
the total synthesis of 1 have been achieved through a
stereochemically divergent strategy that employed macro-
lide-closure by ring-closing metathesis as a key step. Finally,
the stereochemical assignments of the unprecedented 9-
hydroxy-2,4,7-trimethyltetradeca-14-ynoic acid moiety may
be relevant to biosynthetic congeners of 1.
Scheme 6. Elucidation of the configuration of 18a at C7. Reagents and
conditions: a) DDQ (5 equiv), tBuOH, H2O, CH2Cl2, 10 min sonica-
tion, 89%; b) TBDPSCl (1.5 equiv), imidazole (2 equiv), DMAP
(0.1 equiv), CH2Cl2, 3 h, 85%; c) O3, MeOH, 10 min; NaBH4 (2 equiv),
3 h, 77%; d) LiOH (6 equiv), tBuOH/H2O (4:1), 2 h, 74%; e) TEMPO
(0.3 equiv), BAIB (3 equiv), CH2Cl2, 2 h, 65%. DDQ=2,3-dichloro-5,6-
dicyanoquinone, TEMPO=2,2,6,6-tetramethyl-1-piperidinyloxy,
BAIB=iodobenzene diacetate.
Received: January 2, 2004 [Z53663]
Keywords: cyclization · metathesis · natural products ·
.
structure elucidation · total synthesis
epoxide 6 with inversion of configuration during the forma-
tion of 13 and that (S)-N-methylphenylalanine[1] was
employed throughout, 2a was assigned the 2R,4R,7R,9S,16S
configuration.[19]
[1] A. Grassia, I. Bruno, C. Debitus, S. Marzocco, A. Pinto, L.
Gomez-Paloma, R. Riccio, Tetrahedron 2001, 57, 6257.
[2] R. Kazlauskas, P. T. Murphy, R. J. Wells, K. Noack, W. E.
Oberhansli, P. Schonholzer, Aust. J. Chem. 1979, 32, 867.
[3] G. R. Pettit, Z. A. Cichacz, F. Gao, C. L. Herald, M. R. Boyd,
J. M. Schmidt, J. N. A. Hooper, J. Org. Chem. 1993, 58, 1302.
[4] P. Marfey, Carlsberg Res. Commun. 1984, 49, 591.
[5] N. Matsumori, D. Kaneno, M. Murata, H. Nakamura, K.
Tachibana, J. Org. Chem. 1999, 64, 866 – 876.
[6] R. D. Cink, C. J. Forsyth, J. Org. Chem. 1995, 60, 8122.
[7] W. P. Griffith, S. V. Ley, G. P. Whitcombe, A. D. White, Chem.
Commun. 1987, 1625.
[8] L. Lombardo, Tetrahedron Lett. 1982, 23, 4293.
[9] O. Mitsunobu, Synthesis 1991, 1.
To extend the stereochemical assignment of 2a unambig-
uously to 1, the former was further functionalized to complete
a total synthesis. This involved conversion of the C11 alcohol
of 2a into the alkyne-terminated side chain of
(2R,4R,7R,9R,16S)-1. First, the primary alcohol was trans-
formed into iodide 24, which was then treated with allyl tri-n-
butyltin and catalytic AIBN to generate the allylation product
25 (Scheme 7). The resultant alkene was cleaved with K2OsO4
and NaIO4 to give the corresponding aldehyde. Finally, the
Bestmann reagent[20] was employed to convert the aldehyde
into the corresponding terminal alkyne (2R,4R,7R,9R,16S)-1,
which matched natural spongidepsin by 1H and 13C NMR
spectroscopy, HRMS, and specific rotation [synthetic
[10] M. Sakaitani, Y. Ohfune, J. Org. Chem. 1990, 55, 870.
[11] J. Inanaga, K. Hirata, H. Saeki, T. Katsuki, M. Yamaguchi, Bull.
Chem. Soc. Jpn. 1979, 52, 1989.
[12] J. C. Anderson, S. V. Ley, Tetrahedron Lett. 1994, 35, 2087.
Angew. Chem. Int. Ed. 2004, 43, 2148 –2152
ꢀ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2151